Overview
Adenocarcinoma of the cervix is a malignant neoplasm arising from the glandular cells of the cervix, often presenting with atypical glandular cells or abnormal vaginal bleeding. It typically progresses more indolently than squamous cell carcinoma but can still lead to advanced disease if not detected early 12.Diagnosis
Key Diagnostic Criteria: Atypical glandular cells on cytology, abnormal cervical cytology results, and histological confirmation via biopsy 12.
Recommended Tests: Cervical cytology (Pap smear), colposcopy, endocervical sampling, and biopsy for definitive diagnosis 12.
Grading: Tumor staging follows the FIGO staging system, assessing tumor size, lymph node involvement, and metastasis 2.Management
First-Line Treatment: Primary treatment often involves radical hysterectomy for early-stage disease, followed by adjuvant therapy (chemotherapy, radiation) based on stage and risk factors 2.
Adjunctive Treatments: Chemoradiation (e.g., cisplatin-based chemotherapy combined with radiation) for locally advanced disease 2.
Palliative Care: Symptom management and supportive care for advanced stages, including pain control and management of complications 2.Special Populations
Pregnancy: Emergency cerclage may extend pregnancy duration in cases of incompetent cervix, though success rates vary with bulging membranes 3.
Comorbidities: Specific management adjustments may be necessary based on coexisting conditions, though detailed guidance is not provided in the abstracts 2.Key Recommendations
Implement rigorous quality control measures in cytology laboratories to ensure accurate detection of adenocarcinoma (Evidence: Strong 2).
Consider radical hysterectomy for early-stage adenocarcinoma, complemented by adjuvant therapies as indicated by staging (Evidence: Moderate 2).
Evaluate and manage cervical incompetence with emergency cerclage in pregnant patients, acknowledging variable success rates (Evidence: Weak 3).References
1 Hanna MG, Pantanowitz L. Feasibility of using the Omnyx digital pathology system for cytology practice. Journal of the American Society of Cytopathology 2019. link
2 Triol JH, Russell CD, Ashton PR. Health Care Financing Administration/American Society for Cytotechnology inspections: government assessment of cytology laboratory practice under the regulations of the Clinical Laboratory Improvement Amendments of 1988. Archives of pathology & laboratory medicine 1997. link
3 Schorr SJ, Morales WJ. Obstetric management of incompetent cervix and bulging fetal membranes. The Journal of reproductive medicine 1996. link